(Q53590616)

English

Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease

scientific article published in December 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

cardiovascular disease

1 reference

based on heuristic

inferred from title

4

object named as

Nicola Dalbeth

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

Amanda Phipps-Green

object named as

Amanda Phipps-Green

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

10

object named as

Lisa K Stamp

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

object named as

Tony R Merriman

16

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Marilyn Merriman

5

object named as

Marilyn E Merriman

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

author name string

Laura B E Kienhorst

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Ellen van Lochem

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Wietske Kievit

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Arnoud Loof

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Waander van Heerde

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Sita Vermeulen

9

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Elly van Koolwijk

11

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Jacqueline de Graaf

12

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Dirk Holzinger

13

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Johannes Roth

14

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Hein J E M Janssens

15

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Jasper C A Broen

17

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Matthijs Janssen

18

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Timothy R D J Radstake

19

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

publication date

1 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

67

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

12

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

3303-3313

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Epidemiology, risk factors, and lifestyle modifications for gout

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

The broad spectrum of urate crystal deposition: unusual presentations of gouty tophi

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Association of incident gout and mortality in dialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Long-term cardiovascular mortality among middle-aged men with gout

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Gout: an independent risk factor for all-cause and cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Preliminary criteria for the classification of the acute arthritis of primary gout

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

GenePattern 2.0

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Protein identification with N and C-terminal sequence tags in proteome projects

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Risk of incident diabetes in patients with gout: a cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

When gout goes to the heart: does gout equal a cardiovascular disease risk factor?

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men.

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Correlates of axial gout: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

The Janus face of OSM-mediated cardiomyocyte dedifferentiation during cardiac repair and disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Gout-associated uric acid crystals activate the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Bonding the foe - NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Netting neutrophils in autoimmune small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines.

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation

1 reference

https://api.crossref.org/works/10.1002%2FART.39318

21 January 2018

Identifiers

10.1002/ART.39318

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/26248007

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53590616&oldid=1507974977"